214 related articles for article (PubMed ID: 36627626)
41. [Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation].
Huang XL; Wu SH; Shi PF; Xu LH; Chen C; Xie YP; Gao DQ; Chen K; Tan JF; Liu LR; Xu Y; Yang F; Yu MX; Wang SY; Qian SX
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):932-936. PubMed ID: 33333697
[No Abstract] [Full Text] [Related]
42. Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study.
Hu H; Wang Y; Sun J; Wang Y; Zhou J; Shi Q; Han X; Jiang Y; Wu D; Huang X; Yu Y
Microbiol Spectr; 2024 Jun; ():e0429923. PubMed ID: 38847538
[TBL] [Abstract][Full Text] [Related]
43. The Gastrointestinal Load of Carbapenem-Resistant Enterobacteriacea Is Associated With the Transition From Colonization to Infection by
Migliorini LB; Leaden L; de Sales RO; Correa NP; Marins MM; Koga PCM; Toniolo ADR; de Menezes FG; Martino MDV; Mingorance J; Severino P
Front Cell Infect Microbiol; 2022; 12():928578. PubMed ID: 35865821
[TBL] [Abstract][Full Text] [Related]
44. Biofilm and Gene Expression Characteristics of the Carbapenem-Resistant Enterobacterales,
Al-Bayati M; Samarasinghe S
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457654
[TBL] [Abstract][Full Text] [Related]
45. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
[TBL] [Abstract][Full Text] [Related]
46. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
47. Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study.
Kömürcü B; Tükenmez Tigen E; Toptaş T; Fıratlı Tuğlular T; Korten V
Expert Rev Hematol; 2020 Aug; 13(8):923-927. PubMed ID: 32574123
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
Yan L; Sun J; Xu X; Huang S
Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
[TBL] [Abstract][Full Text] [Related]
49. The Likelihood of Developing a Carbapenem-Resistant
Tamma PD; Kazmi A; Bergman Y; Goodman KE; Ekunseitan E; Amoah J; Simner PJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138574
[TBL] [Abstract][Full Text] [Related]
50. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
[TBL] [Abstract][Full Text] [Related]
51. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
52. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
[TBL] [Abstract][Full Text] [Related]
53. Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study.
Chu W; Hang X; Li X; Ye N; Tang W; Zhang Y; Yang X; Yang M; Wang Y; Liu Z; Zhou Q
Infect Drug Resist; 2022; 15():6051-6063. PubMed ID: 36277248
[TBL] [Abstract][Full Text] [Related]
54. Frequency of and risk factors for carbapenem-resistant
Barber KE; Wagner JL; Larry RC; Stover KR
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
[No Abstract] [Full Text] [Related]
55. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
[TBL] [Abstract][Full Text] [Related]
56. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand.
Prakobsrikul N; Malathum K; Santanirand P; Chumnumwat S; Piebpien P; Montakantikul P
J Clin Pharm Ther; 2019 Apr; 44(2):292-299. PubMed ID: 30578578
[TBL] [Abstract][Full Text] [Related]
57. An observational study on carbapenem-resistant Enterobacterales (CRE) colonisation and subsequent risk of infection in an adult intensive care unit (ICU) at a tertiary care hospital in India.
Sharma K; Tak V; Nag VL; Bhatia PK; Kothari N
Infect Prev Pract; 2023 Dec; 5(4):100312. PubMed ID: 37868258
[TBL] [Abstract][Full Text] [Related]
58. Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States.
Karlsson M; Lutgring JD; Ansari U; Lawsin A; Albrecht V; McAllister G; Daniels J; Lonsway D; McKay L; Beldavs Z; Bower C; Dumyati G; Gross A; Jacob J; Janelle S; Kainer MA; Lynfield R; Phipps EC; Schutz K; Wilson L; Witwer ML; Bulens SN; Walters MS; Duffy N; Kallen AJ; Elkins CA; Rasheed JK
Microb Drug Resist; 2022 Apr; 28(4):389-397. PubMed ID: 35172110
[TBL] [Abstract][Full Text] [Related]
59. Characteristics of community-acquired carbapenem-resistant Enterobacterales.
Shrestha R; Luterbach CL; Dai W; Komarow L; Earley M; Weston G; Herc E; Jacob JT; Salata R; Wong D; Anderson D; Rydell KB; Arias CA; Chen L; van Duin D;
J Antimicrob Chemother; 2022 Sep; 77(10):2763-2771. PubMed ID: 36179278
[TBL] [Abstract][Full Text] [Related]
60.
Rao K; Seekatz A; Bassis C; Sun Y; Mantlo E; Bachman MA
mSphere; 2020 Jul; 5(4):. PubMed ID: 32699120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
